Leptin changes differentiation fate and induces senescence in chondrogenic progenitor cells

Cell Death Dis. 2016 Apr 14;7(4):e2188. doi: 10.1038/cddis.2016.68.

Abstract

Body weight is a component of the mechanical theory of OA (osteoarthritis) pathogenesis. Obesity was also found to be a risk factor for digital OA involving non-weight-bearing joints, which suggested that metabolism influences the occurrence and progression of OA. The metabolic origin of OA has been partially attributed to the involvement of adipokines, such as leptin, the levels of which are significantly and positively correlated with cartilage degeneration in OA patients. However, the mechanisms by which leptin-induced cartilage degeneration occurs are poorly understood. The discovery of chondrogenic progenitor cells (CPCs) opened up new opportunities for investigation. Investigating the effects of leptin on differentiation and proliferation in CPCs would increase our understanding of the roles played by leptin in the aetiology and development of OA. Here, CPCs were harvested using single-cell sorting from rat cartilage tissues to obtain mesenchymal stem-like cells, which possess clonogenicity, proliferation and stemness. High doses of leptin decreased the ability of the CPCs to migrate, inhibited their chondrogenic potential and increased their osteogenic potential, suggesting that leptin changes differentiation fates in CPCs. High doses of leptin induced cell cycle arrest and senescence in CPCs by activating the p53/p21 pathway and inhibiting the Sirt1 pathway. Inhibiting the Sirt1 pathway accelerated cartilage senescence in knockout (KO) mice. Activating the leptin pathway induced higher Ob-Rb expression and was significantly correlated with cartilage degeneration (lower levels of Coll-2) and tissue senescence (higher levels of p53/p21 and lower levels of Sirt1) in OA patients, suggesting that leptin-induced CPCs senescence contributes to the development of OA. Taken together, our results reveal new links between obesity and cartilage damage that are induced by leptin-mediated effects on cell behaviour and senescence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cartilage / metabolism
  • Cartilage / pathology
  • Cell Cycle Checkpoints / drug effects
  • Cell Differentiation / drug effects*
  • Cell Movement / drug effects
  • Cells, Cultured
  • Cellular Senescence / drug effects*
  • Chondrocytes / cytology
  • Chondrogenesis / drug effects
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Core Binding Factor Alpha 1 Subunit / metabolism
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Humans
  • Leptin / pharmacology*
  • Mice
  • Mice, Knockout
  • Middle Aged
  • Osteoarthritis / metabolism
  • Osteoarthritis / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Sirtuin 1 / deficiency
  • Sirtuin 1 / genetics
  • Sirtuin 1 / metabolism
  • Stem Cells / cytology
  • Stem Cells / metabolism
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Core Binding Factor Alpha 1 Subunit
  • Cyclin-Dependent Kinase Inhibitor p21
  • Leptin
  • Tumor Suppressor Protein p53
  • Sirt1 protein, mouse
  • Sirtuin 1